Factor Xa Inhibition with Apixaban Does Not Influence Cardiac Remodelling in Rats with Heart Failure After Myocardial Infarction.
Salva R YuristaHerman H W SilljéKirsten T NijholtMartin M DokterDirk J van VeldhuisenRudolf A de BoerB Daan WestenbrinkPublished in: Cardiovascular drugs and therapy (2020)
FXa inhibition with apixaban does not influence pathological cardiac remodelling after MI. These data do not support the use of FXa inhibitor in HF patients with the aim to amend the severity of HF. Graphical Abstract.
Keyphrases